首页> 外文期刊>Strahlentherapie und Onkologie >Prognostic factors for locoregional recurrence after neoadjuvant chemotherapy: Results of a combined analysis from NSABP B-18 and B-27 [Pr?diktoren für ein lokoregion?res Rezidiv nach neoadjuvanter Chemotherapie beim Mammakarzinom: Ergebnisse der kombinierten Analyse von NSAB B-18 und B-27]
【24h】

Prognostic factors for locoregional recurrence after neoadjuvant chemotherapy: Results of a combined analysis from NSABP B-18 and B-27 [Pr?diktoren für ein lokoregion?res Rezidiv nach neoadjuvanter Chemotherapie beim Mammakarzinom: Ergebnisse der kombinierten Analyse von NSAB B-18 und B-27]

机译:新辅助化疗后局部复发的预后因素:NSABP B-18和B-27的联合分析结果-27]

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hippocampal sclerosis (HS) is the most frequent histopathology encountered in patients with drug-resistant temporal lobe epilepsy (TLE). Over the past decades, various attempts have been made to classify specific patterns of hippocampal neuronal cell loss and correlate subtypes with postsurgical outcome. However, no international consensus about definitions and terminology has been achieved. A task force reviewed previous classification schemes and proposes a system based on semiquantitative hippocampal cell loss patterns that can be applied in any histopathology laboratory. Interobserver and intraobserver agreement studies reached consensus to classify three types in anatomically well-preserved hippocampal specimens: HS International League Against Epilepsy (ILAE) type 1 refers always to severe neuronal cell loss and gliosis predominantly in CA1 and CA4 regions, compared to CA1 predominant neuronal cell loss and gliosis (HS ILAE type 2), or CA4 predominant neuronal cell loss and gliosis (HS ILAE type 3). Surgical hippocampus specimens obtained from patients with TLE may also show normal content of neurons with reactive gliosis only (no-HS). HS ILAE type 1 is more often associated with a history of initial precipitating injuries before age 5 years, with early seizure onset, and favorable postsurgical seizure control. CA1 predominant HS ILAE type 2 and CA4 predominant HS ILAE type 3 have been studied less systematically so far, but some reports point to less favorable outcome, and to differences regarding epilepsy history, including age of seizure onset. The proposed international consensus classification will aid in the characterization of specific clinicopathologic syndromes, and explore variability in imaging and electrophysiology findings, and in postsurgical seizure control.
机译:海马硬化(HS)是耐药性颞叶癫痫(TLE)患者中最常见的组织病理学。在过去的几十年中,已经进行了各种尝试来对海马神经元细胞丢失的特定模式进行分类,并将亚型与术后结果相关联。但是,尚未就定义和术语达成国际共识。一个工作队审查了以前的分类方案,并提出了一种基于半定量海马细胞丢失模式的系统,该系统可应用于任何组织病理学实验室。观察者间和观察者内协议研究达成共识,将解剖学上保存完好的海马标本分为三种类型:HS国际抗癫痫联盟(ILAE)1型始终指的是严重的神经元细胞丢失和神经胶质变性,而CA1和CA4则为主要神经元细胞丢失和神经胶质增生(HS ILAE 2型)或以CA4为主的神经元细胞丢失和神经胶质增生(HS ILAE 3型)。从TLE患者获得的外科海马标本也可能显示神经元含量正常,仅具有反应性神经胶质增生(无HS)。 HS ILAE 1型更常与5岁之前开始有先发性损伤史,发作较早以及术后癫痫发作控制良好有关。到目前为止,对CA1为主的HS ILAE 2型和CA4为主的HS ILAE 2型的研究较少,但是一些报告指出结果较差,并且在癫痫病史(包括发作的年龄)方面也存在差异。拟议的国际共识分类将有助于表征特定的临床病理综合征,并探讨影像学和电生理学发现以及术后癫痫发作控制的变异性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号